These results were supported by the correlation between the estimated cumulative 5-year survival rates of cervical carcinoma patients and the expression levels of FOXO3a (81.6% high vs. 58.8% low) and β-catenin (59.4% high vs. 81.3% low). Here, FOXO3 is linked to cervical carcinoma.